🇺🇸 FDA
Patent

US 8349568

Method of diagnosing poor survival prognosis colon cancer using let-7g

granted A61PA61P1/04A61P35/00

Quick answer

US patent 8349568 (Method of diagnosing poor survival prognosis colon cancer using let-7g) held by The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/04, A61P35/00